Corvus Pharma Com (CRVS)

$2.03 0.00 (0.00%)

16:00 EDT CRVS Stock Quote Delayed 30 Minutes

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024

By InvestorPlace Earnings May 6, 2024

CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the first quarter of 2024.

CRVS Stock Earnings: Corvus Pharma Misses EPS for Q4 2023

3 High-Potential Penny Stocks to Buy Now

7 High-Potential Penny Stocks in the Biotech Sector

More Articles

Volume:

Previous Close -

Market Cap 126,979

PE Ratio -3.98

EPS -0.51

Volume (Avg. Vol.)

Day's Range -

52-Week Range $1.05 - $4.19

Dividend & Yield N/A (N/A)

CRVS Stock Predictions, Articles, and Corvus Pharma Com News

From InvestorPlace
From the Web

The 3 Best Biotech Stocks Under $1 to Buy for April

By Ian Cooper, InvestorPlace Contributor Apr 4, 2023

While risky, here are some of the best biotech stocks under $1, with solid catalysts, investors may want to consider.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 21, 2021

Good morning, trader! Another busy day of trading is already underway as we look at the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 20, 2021

Welcome back, trader! We're starting off the week right with a dive into the biggest pre-market stock movers for Monday morning.

12 Things to Know About Biotech Penny Stock Corvus Pharmaceuticals (CRVS) as Shares Rocket

By William White, InvestorPlace Writer Sep 17, 2021

Corvus Pharmaceuticals (CRVS) stock is rising higher on heavy trading volume Friday despite a lack of news from the company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 17, 2021

There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 16, 2021

Good morning. investor! We're over halfway through the week now but we're not slacking with our biggest pre-market stock movers for Thursday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 16, 2021

It's been a busy week of trading but it's almost over. Join me as we start Friday with a look at the biggest pre-market stock movers!

Corvus lymphoma drug gets FDA orphan drug status (NASDAQ:CRVS)

From Seeking Alpha Feb 8, 2024

Corvus Pharmaceuticals (CRVS) receives FDA Orphan Drug Designation for soquelitinib, a potential treatment for T-cell lymphoma. Read more here.

Corvus Pharmaceuticals (CRVS) Receives a Hold from Mizuho Securities

From TipRanks Dec 13, 2022

In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Hold rating on Corvus Pharmaceuticals (CRVS – Research Report), ...

Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Corvus Pharmaceuticals (CRVS)

From TipRanks Nov 4, 2022

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insulet (

Mizuho Securities Keeps Their Hold Rating on Corvus Pharmaceuticals (CRVS)

From TipRanks Aug 9, 2022

In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Hold rating on Corvus Pharmaceuticals (CRVS – Research Report), with a pric...

Recap: Corvus Pharmaceuticals Q4 Earnings

From Benzinga Mar 10, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

A Preview Of Corvus Pharmaceuticals's Earnings

From Benzinga Mar 9, 2022

Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....

ADVERTISEMENT